Latest news
DMAC: Positive clinical progress and strong cash runway, despite higher net loss from expanded trials - TradingViewTradingView · Tue, 11 Aug 2026 07:24:22 GMTTRVI: Advanced Haduvio trials and strong cash position, but net loss rose and more funding is needed - TradingViewTradingView · Thu, 06 Aug 2026 20:18:44 GMTEYPT: Q2 2026 revenue fell 90% and net loss rose 59% as R&D spending surged for DURAVYU trials - TradingViewTradingView · Wed, 05 Aug 2026 20:07:27 GMTCommunity Concern Grows Over Whitsundays Tunnel Net Trials - Mackay & Whitsunday LifeMackay & Whitsunday Life · Wed, 05 Aug 2026 08:21:43 GMT